tiprankstipranks
Quantum Genomics (QNNTF)
OTHER OTC:QNNTF

Quantum Genomics (QNNTF) Stock News & Sentiment

5 Followers
Quantum Genomics Announces Lack of Significant Efficacy for Firibastat in Their Phase III Study, FRESH and is Redirecting to New Developments
PremiumPress Releases
Quantum Genomics Announces Lack of Significant Efficacy for Firibastat in Their Phase III Study, FRESH and is Redirecting to New Developments
1y ago
Bryan Garnier & Co Initiates the Coverage of Quantum Genomics with a Target Price at 13€ per Share
PremiumPress Releases
Bryan Garnier & Co Initiates the Coverage of Quantum Genomics with a Target Price at 13€ per Share
2y ago
Quantum Genomics Publishes its 2022 First Half Results and Reviews its Activity
PremiumPress Releases
Quantum Genomics Publishes its 2022 First Half Results and Reviews its Activity
2y ago

QNNTF News on the Web

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

Not enough data to generate Media Coverage Analysis
The historical news coverage of this asset in the last three months.

FAQ

What is QNNTF’s Media Buzz Sentiment?
Currently, no data Available
What is QNNTF’s weekly average amount of articles?
Currently, no data Available
What is QNNTF’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
STROSutro Biopharma
ERASErasca
THRDThird Harmonic Bio, Inc.
STOKStoke Therapeutics
BCABBioAtla
Showing the stocks with the most bullish news sentiment over the past week
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis